221 related articles for article (PubMed ID: 8081359)
21. Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2.
Zhu Y; Doll MA; Hein DW
Biol Chem; 2002 Jun; 383(6):983-7. PubMed ID: 12222688
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanism of slow acetylation of drugs and carcinogens in humans.
Blum M; Demierre A; Grant DM; Heim M; Meyer UA
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5237-41. PubMed ID: 1675794
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
Zang Y; Doll MA; Zhao S; States JC; Hein DW
Carcinogenesis; 2007 Aug; 28(8):1665-71. PubMed ID: 17434923
[TBL] [Abstract][Full Text] [Related]
24. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel allele at the human NAT1 acetyltransferase locus.
Doll MA; Jiang W; Deitz AC; Rustan TD; Hein DW
Biochem Biophys Res Commun; 1997 Apr; 233(3):584-91. PubMed ID: 9168895
[TBL] [Abstract][Full Text] [Related]
26. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
Doll MA; Zang Y; Moeller T; Hein DW
J Pharmacol Exp Ther; 2010 Aug; 334(2):540-4. PubMed ID: 20430842
[TBL] [Abstract][Full Text] [Related]
27. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases.
Hein DW; Rustan TD; Ferguson RJ; Doll MA; Gray K
Arch Toxicol; 1994; 68(2):129-33. PubMed ID: 8179482
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.
Zang Y; Zhao S; Doll MA; States JC; Hein DW
Pharmacogenet Genomics; 2007 Jan; 17(1):37-45. PubMed ID: 17264801
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
31. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition.
Fretland AJ; Doll MA; Zhu Y; Smith L; Leff MA; Hein DW
Cancer Detect Prev; 2002; 26(1):10-4. PubMed ID: 12088197
[TBL] [Abstract][Full Text] [Related]
32. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
33. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
34. Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
Fakis G; Boukouvala S; Kawamura A; Kennedy S
Pharmacogenet Genomics; 2007 Mar; 17(3):181-8. PubMed ID: 17460546
[TBL] [Abstract][Full Text] [Related]
35. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Cascorbi I; Drakoulis N; Brockmöller J; Maurer A; Sperling K; Roots I
Am J Hum Genet; 1995 Sep; 57(3):581-92. PubMed ID: 7668286
[TBL] [Abstract][Full Text] [Related]
36. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 Feb; 291(1):116-23. PubMed ID: 11829470
[TBL] [Abstract][Full Text] [Related]
37. Human
Hein DW; Doll MA; Habil MR
Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898
[TBL] [Abstract][Full Text] [Related]
38. 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2.
Metry KJ; Zhao S; Neale JR; Doll MA; States JC; McGregor WG; Pierce WM; Hein DW
Mol Carcinog; 2007 Jul; 46(7):553-63. PubMed ID: 17295238
[TBL] [Abstract][Full Text] [Related]
39. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
40. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]